NEW DELHI: Firming up its stand on prophylactic use of HCQ, the Indian Council of Medical Research (ICMR) has cited findings of its casecontrolled study which showed that a sustained intake of the anti-malarial drug along with appropriate use of personal protective equipment (PPE) led to a significant decline of Covid-19 risk, by up to 80%, among healthcare workers.
According to the findings published in the Indian Journal of Medical Research (IJMR), consumption of four or more maintenance doses was associated with a significant decline (>80%) in the risk of Covid-19 infection among the participants.
Despite WHO suspending trials using HCQ, ICMRRead More – Source
NEW DELHI: Firming up its stand on prophylactic use of HCQ, the Indian Council of Medical Research (ICMR) has cited findings of its casecontrolled study which showed that a sustained intake of the anti-malarial drug along with appropriate use of personal protective equipment (PPE) led to a significant decline of Covid-19 risk, by up to 80%, among healthcare workers.
According to the findings published in the Indian Journal of Medical Research (IJMR), consumption of four or more maintenance doses was associated with a significant decline (>80%) in the risk of Covid-19 infection among the participants.
Despite WHO suspending trials using HCQ, ICMRRead More – Source
